• search hit 9 of 10
Back to Result List

Follow-up of the randomized ASAP trial shows no survival advantage for patients with poor responsive or relapsed AML who received intensive salvagec chemotherapy for remission induction prior to allogeneic transplantation compared to immediate allogeneic transplantation [Abstract]

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, Eva-Maria Wagner Drouet, Lutz Peter Hermann Mueller, Christoph SchmidORCiDGND, Stefan W. Krause, Wolfgang Andreas Bethge, Edgar Jost, Uwe Platzbecker, Stefan Klein, Judith Niederland, Martin Kaufmann, Kerstin Schäfer-Eckart, Henning Baldauf, Friedrich Stölzel, Sarah Trost, Christoph Röllig, Malte von Bonin, Katharina Egger-Heidrich, Désirée Kunadt, Björn Steffen, Beate Hauptrock, Christoph Schliemann, Katja Sockel, Fabian Lang, Oliver Kriege, Judith Schaffrath, Christian Reicherts, Wolfgang E. Berdel, Hubert Serve, Gerhard Ehninger, Alexander H. Schmidt, Jan-Henrik Mikesch, Martin Bornhäuser, Johannes Schetelig
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/117412
ISSN:0006-4971OPAC
ISSN:1528-0020OPAC
Parent Title (English):Blood
Publisher:American Society of Hematology
Place of publication:Washington, DC
Type:Article
Language:English
Year of first Publication:2024
Publishing Institution:Universität Augsburg
Release Date:2024/12/09
Volume:144
Issue:Supplement 1
First Page:776
DOI:https://doi.org/10.1182/blood-2024-204763
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Professur für Transplantation und Zelltherapieforschung